DOYLE JOHN BRENDAN (Chief Financial Officer) received a stock award from COGNITION THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2025ACC: 0001062993-25-001620
Officer· Chief Financial Officer
Since Feb 2026
+295K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
295K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+295K
Price / share
—
Trade value
—
% of position
243.6%
2/4/2025
121.13K→416.13K
Total
Net shares
+295K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | A · Award | +295K | — | — | 243.6% | 121.13K | 416.13K |
| Total | +295K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported